Breaking News

Wednesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
MGEN

Miragen Therapeutics

$2.63

0.065 (2.54%)

16:10
03/13/19
03/13
16:10
03/13/19
16:10
Earnings
Miragen Therapeutics says has sufficient funds through Q1 of 2020 »

The company believes that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Mar

  • 19

    Mar

MGEN

Miragen Therapeutics

$2.62

0.06 (2.34%)

16:07
03/13/19
03/13
16:07
03/13/19
16:07
Earnings
Miragen Therapeutics reports Q4 EPS (33c), consensus (31c) »

Reports Q4 revenue $0.5M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Mar

  • 19

    Mar

Over a month ago
MNK

Mallinckrodt

$20.20

0.25 (1.25%)

, MGEN

Miragen Therapeutics

$3.40

-0.12 (-3.41%)

04:55
01/12/19
01/12
04:55
01/12/19
04:55
Conference/Events
Jonathan Wood & Associates to hold a forum »

11th Annual T-Cell…

MNK

Mallinckrodt

$20.20

0.25 (1.25%)

MGEN

Miragen Therapeutics

$3.40

-0.12 (-3.41%)

SPPI

Spectrum

$11.07

0.195 (1.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

MNK

Mallinckrodt

$19.95

0.67 (3.48%)

, MGEN

Miragen Therapeutics

$3.52

-0.66 (-15.79%)

04:55
01/11/19
01/11
04:55
01/11/19
04:55
Conference/Events
Jonathan Wood & Associates to hold a forum »

11th Annual T-Cell…

MNK

Mallinckrodt

$19.95

0.67 (3.48%)

MGEN

Miragen Therapeutics

$3.52

-0.66 (-15.79%)

SPPI

Spectrum

$10.87

0.56 (5.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

MNK

Mallinckrodt

$19.28

0.3 (1.58%)

, MGEN

Miragen Therapeutics

$4.18

0.03 (0.72%)

08:30
01/10/19
01/10
08:30
01/10/19
08:30
Conference/Events
Jonathan Wood & Associates to hold a forum »

11th Annual T-Cell…

MNK

Mallinckrodt

$19.28

0.3 (1.58%)

MGEN

Miragen Therapeutics

$4.18

0.03 (0.72%)

SPPI

Spectrum

$10.31

0.1 (0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

  • 18

    Feb

MGEN

Miragen Therapeutics

$4.18

0.03 (0.72%)

07:10
01/10/19
01/10
07:10
01/10/19
07:10
Hot Stocks
Miragen Therapeutics announces data from Phase 1 cobomarsen trial »

Miragen Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

MGEN

Miragen Therapeutics

$3.19

-0.15 (-4.49%)

08:58
01/04/19
01/04
08:58
01/04/19
08:58
Initiation
Miragen Therapeutics initiated at Baird »

Miragen Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

  • 10

    Jan

MGEN

Miragen Therapeutics

$3.19

-0.15 (-4.49%)

16:10
01/03/19
01/03
16:10
01/03/19
16:10
Hot Stocks
683 Capital Partners reports 5.5% passive stake in Miragen Therapeutics »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

  • 10

    Jan

MGEN

Miragen Therapeutics

$2.69

-0.035 (-1.29%)

04:52
12/31/18
12/31
04:52
12/31/18
04:52
Initiation
Miragen Therapeutics initiated at B. Riley FBR »

Miragen Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

  • 10

    Jan

MGEN

Miragen Therapeutics

$2.66

(0.00%)

07:08
12/20/18
12/20
07:08
12/20/18
07:08
Hot Stocks
Miragen Therapeutics to present new data from Phase 1 cobomarsen trial »

Miragen Therapeutic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.